Cannabinoid CB2 Receptor

Medical Marijuana in the treatment of Multiple Sclerosis.
Post Reply
User avatar
Petr75
Family Elder
Posts: 1610
Joined: Sat Oct 19, 2013 10:17 am
Location: Czech Republic
Contact:

Cannabinoid CB2 Receptor

Post by Petr75 »

2019 Aug 13
Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.
https://www.ncbi.nlm.nih.gov/pubmed/31407233

Abstract
The cannabinoid system has been identified as a critical endogenous regulator of immune homeostasis through immunomodulatory actions. This system is one of the main regulatory systems of the central nervous system (CNS). Variations in the cannabinoid CB2 receptor gene (CNR2) could affect intracellular signaling and reduce system function, which has been associated with an unbalanced immune response and increased risk of a variety of autoimmune inflammatory disorders. The present study investigated the relationship between CNR2 rs35761398 (Q63R) functional variation and multiple sclerosis (MS). A total of 100 Iranian MS patients and 100 healthy controls were enrolled in the study and genotyped through TaqMan assay. The co-dominant, dominant, recessive, over-dominant, and additive inheritance models were analyzed using SNPStats software. A significant genetic association was observed between Q63R polymorphism and MS. The dominant model was accepted as the best inheritance model to fit the data (OR 2.70, 95% CI 1.47-4.97, p = 0.001). The data implied the involvement of the CNR2 gene in susceptibility to MS in Iranian patients.
https://www.eboro.cz
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Medical Marijuana”